清脆的
胞嘧啶
白血病
脱氨基
淋巴细胞白血病
胞苷
胸腺嘧啶
DNA
胞苷脱氨酶
回文
分子生物学
癌症研究
计算生物学
化学
生物
基因
生物化学
遗传学
酶
作者
Robert Chiesa,Christos Georgiadis,Farhatullah Syed,Hong Zhan,Annie Etuk,Soragia Athina Gkazi,Roland Preece,Giorgio Ottaviano,Toni Braybrook,Jan Chu,Agnieszka Kubat,Stuart Adams,Rebecca Thomas,Kimberly Gilmour,David O’Connor,Ajay Vora,Waseem Qasim
标识
DOI:10.1056/nejmoa2300709
摘要
The interim results of this phase 1 study support further investigation of base-edited T cells for patients with relapsed leukemia and indicate the anticipated risks of immunotherapy-related complications. (Funded by the Medical Research Council and others; ISRCTN number, ISRCTN15323014.).
科研通智能强力驱动
Strongly Powered by AbleSci AI